FILTER
FILTERED INTERVIEW RESULTS
Shabbir Dahod
PRESIDENT AND CEO, TRACELINK
TraceLink is the world’s largest integrated digital supply network connecting the life sciences supply chain.
Christiana Goh Bardon
MD, MBA, MANAGING DIRECTOR, UBS ONCOLOGY IMPACT FUND MANAGED BY MPM CAPITAL & PORTFOLIO MANAGER, BURRAGE CAPITAL FUND
UBS Oncology Impact Fund is an evergreen fund specializing in investments in early stage oncology and cancer therapeutics.
Geoff Meyerson
CEO AND CO-FOUNDER, LOCUST WALK
Locust Walk is a global life science transaction firm with an integrated team-based approach across capabilities, geographies, and industry segments to deliver the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.
Jonathan Retano
FOUNDER AND CEO, PHARMAFUSION
Pharmafusion provides data warehouse and business analytics solutions for the pharmaceutical industry.
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER AT PORZIO LIFE SCIENCES
Porzio Life Sciences is dedicated to helping pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment.
Paul Hennessey
SENIOR VP SALES, CONTRACT PHARMACAL CORP. (CPC)
Contract Pharmacal Corp. manufactures and packages pharmaceuticals, over-the-counter drugs and dietary supplements.
Robert K. Coughlin
PRESIDENT & CEO, MASSBIO
MassBio’s mission is to advance Massachusetts' leadership in life sciences to grow the industry, add value to the healthcare system and improve patient lives.
Jennifer Hawks Bland
CEO, NEWYORKBIO
NewYorkBIO brings together New York’s bioscience stakeholders to advance life science research and commercialization.
Eric Falcand
VICE PRESIDENT, HEAD OF BUSINESS DEVELOPMENT AND LICENSING, SERVIER GROUP
Servier is strengthening its oncology portfolio and widneing its U.S. footprint.
James Greenwood
PRESIDENT & CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
The Biotechnology Innovation Organization (BIO) represents biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
